Back

Myeloid Tgfbr1/2-deficiency leads to a pro-atherogenic environment in ApoE-/- mice

31 August 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Novel mechanisms of atherosclerosis Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Venetia Bazioti

Ludwig Maximilians University, Munich (Germany)

7 More presentations in this session

Presentation thumbnail
Inhibiting chondroitin sulfate synthase 1 ameliorates hyperplastic arterial remodelling
Doctor D. Liao (Singapore, SG) Mr W. Chng (SG)
Abstract Slides Video
Presentation thumbnail
A novel VCP modulator, KUS121, attenuates atherosclerosis progression by maintaining intracellular ATP and mitigating ER stress in endothelial cells
Doctor O. Baba (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease
Doctor V. Nankivell (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis
Doctor M. Drozd (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Profiling the L-arginine/arginase 1 metabolism in early and advanced atherosclerosis
Mrs Y. Wu (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Novel mechanisms of atherosclerosis

The Event

Event poster

ESC Congress 2024

31 August 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
B Cell TGF-beta1 deficiency prevents VSMC-macrophage phenotype shift and ameliorates advanced atherosclerosis
thumbnail
Congress Presentation
Therapeutic targeting of inflammation in atherosclerosis
thumbnail
Congress Session
Immune modulation in cardiovascular injury and remodelling

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources